Bracco Diagnostics Inc. v. Maia Pharmaceuticals, Inc., No. 20-1387 (Fed. Cir. Dec. 17, 2020)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Maia Pharmaceuticals, Inc. (“Maia”) appeals from a judgment of the United States District Court for the Dis- trict of New Jersey that Maia’s sincalide product infringes U.S. Patent 6,803,046 (“the ’046 patent”), owned by Bracco Diagnostics, Inc. (“Bracco”). J.A. 1 –8. The court entered the judgment pursuant to a stipulation of infringement by the parties in view of the court’s claim construction of the terms buffer, surfactant/solubilizer, and surfactant. Bracco Diagnostics, Inc. v. Maia Pharms., Inc., No. 3:17-cv- 13151, 2019 WL 4885888 (D.N.J. Oct.